Royal Bank of Canada’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $38K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $0 | Sell |
|
|||||
|
2024
Q1 | $937K | Buy |
|
|||||
|
2023
Q4 | $654K | Sell |
|
|||||
|
2023
Q3 | $689K | Buy |
|
|||||
|
2023
Q2 | $90K | Sell |
|
|||||
|
2023
Q1 | $188K | Hold |
|
|||||
|
2022
Q4 | $122K | Sell |
|
|||||
|
2022
Q3 | $127K | Buy |
|
|||||
|
2022
Q2 | $140K | Sell |
|
|||||
|
2022
Q1 | $205K | Buy |
|
|||||
|
2021
Q4 | $57K | Buy |
|